Skip to main content

previous disabled Page of 2
and
  1. Article

    Open Access

    LDLR-Gene therapy for familial hypercholesterolaemia: problems, progress, and perspectives

    Coronary artery diseases (CAD) inflict a heavy economical and social burden on most populations and contribute significantly to their morbidity and mortality rates. Low-density lipoprotein receptor (LDLR) asso...

    Faisal A Al-Allaf, Charles Coutelle in International Archives of Medicine (2010)

  2. No Access

    Article

    Development of S/MAR minicircles for enhanced and persistent transgene expression in the mouse liver

    We have previously described the development of a scaffold/matrix attachment region (S/MAR) episomal vector system for in vivo application and demonstrated its utility to sustain transgene expression in the mo...

    Orestis Argyros, Suet ** Wong, Constantinos Fedonidis in Journal of Molecular Medicine (2011)

  3. No Access

    Article

    The CD46-Jagged1 interaction is critical for human TH1 immunity

    The complement receptor CD46 and the Notch-Jagged system are important for the differentiation of helper T cells. Kemper and colleagues demonstrate that Jagged1 is a physiological ligand for CD46 and is critic...

    Gaëlle Le Friec, Devon Sheppard, Pat Whiteman, Christian M Karsten in Nature Immunology (2012)

  4. No Access

    Article

    Increased glucocerebrosidase (GBA) 2 activity in GBA1 deficient mice brains and in Gaucher leucocytes

    Lysosomal glucocerebrosidase (GBA1) deficiency is causative for Gaucher disease. Not all individuals with GBA1 mutations develop neurological involvement raising the possibility that other factors may provide ...

    Derek G. Burke, Ahad A. Rahim in Journal of Inherited Metabolic Disease (2013)

  5. Article

    Erratum to: Increased glucocerebrosidase (GBA) 2 activity in GBA1 deficient mice brains and in Gaucher leucocytes

    Derek G. Burke, Ahad A. Rahim in Journal of Inherited Metabolic Disease (2013)

  6. Article

    Open Access

    In vivo bioimaging with tissue-specific transcription factor activated luciferase reporters

    The application of transcription factor activated luciferase reporter cassettes in vitro is widespread but potential for in vivo application has not yet been realized. Bioluminescence imaging enables non-invasive...

    Suzanne M. K. Buckley, Juliette M. K. M. Delhove, Dany P. Perocheau in Scientific Reports (2015)

  7. Article

    Open Access

    A Broad Overview and Review of CRISPR-Cas Technology and Stem Cells

    The pinnacle of four decades of research, induced pluripotent stem cells (iPSCs), and genome editing with the advent of clustered, regularly interspaced, short palindromic repeats (CRISPR) now promise to take ...

    Simon N. Waddington, Riccardo Privolizzi, Rajvinder Karda in Current Stem Cell Reports (2016)

  8. Article

    Open Access

    Modeling hormonal and inflammatory contributions to preterm and term labor using uterine temporal transcriptomics

    Preterm birth is now recognized as the primary cause of infant mortality worldwide. Interplay between hormonal and inflammatory signaling in the uterus modulates the onset of contractions; however, the relativ...

    Roberta Migale, David A. MacIntyre, Stefano Cacciatore, Yun S. Lee in BMC Medicine (2016)

  9. Article

    Open Access

    Regulation of post-Golgi LH3 trafficking is essential for collagen homeostasis

    Post-translational modifications are necessary for collagen precursor molecules (procollagens) to acquire final shape and function. However, the mechanism and contribution of collagen modifications that occur ...

    Blerida Banushi, Federico Forneris, Anna Straatman-Iwanowska in Nature Communications (2016)

  10. Article

    Open Access

    Longitudinal in vivo bioimaging of hepatocyte transcription factor activity following cholestatic liver injury in mice

    Molecular mechanisms regulating liver repair following cholestatic injury remain largely unknown. We have combined a mouse model of acute cholestatic liver injury, partial bile duct ligation (pBDL), with a nov...

    Juliette M. K. M. Delhove, Suzanne M. K. Buckley, Dany P. Perocheau in Scientific Reports (2017)

  11. Article

    Open Access

    Lentiviral vectors can be used for full-length dystrophin gene therapy

    Duchenne Muscular Dystrophy (DMD) is caused by a lack of dystrophin expression in patient muscle fibres. Current DMD gene therapy strategies rely on the expression of internally deleted forms of dystrophin, mi...

    John R. Counsell, Zeinab Asgarian, **hong Meng, Veronica Ferrer in Scientific Reports (2017)

  12. Article

    Open Access

    Lentiviral vectors can be used for full-length dystrophin gene therapy

    Duchenne Muscular Dystrophy (DMD) is caused by a lack of dystrophin expression in patient muscle fibres. Current DMD gene therapy strategies rely on the expression of internally deleted forms of dystrophin, mi...

    John R. Counsell, Zeinab Asgarian, **hong Meng, Veronica Ferrer in Scientific Reports (2017)

  13. Article

    Open Access

    Expanding the phenotype in argininosuccinic aciduria: need for new therapies

    This UK-wide study defines the natural history of argininosuccinic aciduria and compares long-term neurological outcomes in patients presenting clinically or treated prospectively from birth with ammonia-lower...

    Julien Baruteau, Elisabeth Jameson in Journal of Inherited Metabolic Disease (2017)

  14. Article

    Open Access

    Gene therapy for monogenic liver diseases: clinical successes, current challenges and future prospects

    Over the last decade, pioneering liver-directed gene therapy trials for haemophilia B have achieved sustained clinical improvement after a single systemic injection of adeno-associated virus (AAV) derived vect...

    Julien Baruteau, Simon N. Waddington in Journal of Inherited Metabolic Disease (2017)

  15. Article

    Open Access

    Continual conscious bioluminescent imaging in freely moving somatotransgenic mice

    Luciferase bioimaging in living animals is increasingly being applied in many fields of biomedical research. Rodent imaging usually involves anaesthetising the animal during data capture, however, the biologic...

    Rajvinder Karda, Dany P. Perocheau, Natalie Suff, Joanne Ng in Scientific Reports (2017)

  16. Article

    Open Access

    Erratum: Lentiviral vectors can be used for full-length dystrophin gene therapy

    Scientific Reports 7: Article number: 44775; published online: 17 March 2017; updated: 29 August 2017. This article was published twice in error during a change in production systems. The publisher apologizes ...

    John R. Counsell, Zeinab Asgarian, **hong Meng, Veronica Ferrer in Scientific Reports (2017)

  17. Article

    Open Access

    Argininosuccinic aciduria fosters neuronal nitrosative stress reversed by Asl gene transfer

    Argininosuccinate lyase (ASL) belongs to the hepatic urea cycle detoxifying ammonia, and the citrulline-nitric oxide (NO) cycle producing NO. ASL-deficient patients present argininosuccinic aciduria characteri...

    Julien Baruteau, Dany P. Perocheau, Joanna Hanley in Nature Communications (2018)

  18. No Access

    Article

    Fetal gene therapy for neurodegenerative disease of infants

    For inherited genetic diseases, fetal gene therapy offers the potential of prophylaxis against early, irreversible and lethal pathological change. To explore this, we studied neuronopathic Gaucher disease (nGD...

    Giulia Massaro, Citra N. Z. Mattar, Andrew M. S. Wong, Ernestas Sirka in Nature Medicine (2018)

  19. Article

    Open Access

    Production of lentiviral vectors using novel, enzymatically produced, linear DNA

    The manufacture of large quantities of high-quality DNA is a major bottleneck in the production of viral vectors for gene therapy. Touchlight Genetics has developed a proprietary abiological technology that ad...

    Rajvinder Karda, John R. Counsell, Kinga Karbowniczek, Lisa J. Caproni in Gene Therapy (2019)

  20. Article

    Open Access

    In Utero Gene Therapy (IUGT) Using GLOBE Lentiviral Vector Phenotypically Corrects the Heterozygous Humanised Mouse Model and Its Progress Can Be Monitored Using MRI Techniques

    In utero gene therapy (IUGT) to the fetal hematopoietic compartment could be used to treat congenital blood disorders such as β-thalassemia. A humanised mouse model of β-thalassemia was used, in which heterozy...

    Panicos Shangaris, Stavros P. Loukogeorgakis, Sindhu Subramaniam in Scientific Reports (2019)

previous disabled Page of 2